This study aims to investigate the preventive and therapeutic effects of DHM on NAFLD by modulating the intestinal flora and inhibiting the TLR4/NF-κB signaling pathway. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.